Director comments on the role for malaria vaccines
Dr. David Kaslow reflects on progress, challenges, and lessons learned
Read more »
Photo by John-Michael Maas / Darby Films
Partnering with us
We are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.
Our portfolio
We maintain a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.
What we do and how we do it
We identify potentially promising malaria vaccine approaches and systematically move them through the development process. At the same time, we work to catalyze access to a successful malaria vaccine in the countries that need it most.
Community perceptions of a malaria vaccine in the Kintampo districts of Ghana
Article in Malaria Journal reports knowledge and perceptions of community members in the Kintampo area of Ghana where malaria vaccine trials have been ongoing.
Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities
Article about malaria vaccine R&D in the Vaccine supplement dedicated in full to the Decade of Vaccines.
MVI and Inovio Pharmaceuticals to accelerate development of malaria vaccines and delivery technologies
Follow-on collaboration expected to lead to clinical trials.
Community perceptions of malaria and vaccines in two districts of Mozambique
Article in Malaria Journal explores sociocultural and health communications issues among individuals at the community level who are responsible for decisions about vaccine use.
Multilateral Initiative on Malaria (MIM) Pan African Malaria Conference
October 6–11, 2013
Twitter
Flickr